Generate Biomedicines
PrivateLast Round
IPO Announced
Feb 26, 2026
Est. Valuation
$2.04B
Total Funding Raised
$693M
Momentum Score
25 /100
Company Overview
Generate Biomedicines is a biotechnology company that utilizes a generative biology platform to create innovative drugs across various protein modalities and therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Generate Biomedicines Comps
Public and private peers based on sector, stage, and business model.
Generate Biomedicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO Announced | Feb 26, 2026 | ||||
| Series C | Sep 14, 2023 | ||||
| Series B | Nov 18, 2021 | ||||
| Series A | Sep 10, 2020 | ||||
| Seed | Jan 1, 2018 |
Key People
Founding team and executive leadership
Generate Biomedicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Guggenheim Securities | IPO |
| Altitude Life Science Ventures | Series B |
| Morningside Ventures | Series B |
| Fidelity Management & Research Company | Series B, Series C |
| Morgan Stanley | IPO |
| ARCH Venture Partners | Series B, Series C |
| T. Rowe Price | Series B, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2026
Job posting suggests operations aligned with public company reporting and SEC filings.
- Apr 2, 2026
Respiratory portfolio programs for asthma and COPD in Phase 2 and Phase 3 trials.
Generate Biomedicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Generate Biomedicines's valuation, stock price, and market status.
